Results 31 to 40 of about 78,171 (296)

Cladosporium herbarum Hot-Tub Lung Hypersensitivity Pneumonitis in a Greenhouse Worker

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2020
Hypersensitivity pneumonitis is understood to be a delayed allergic reaction to the repeated exposure of a usually innocent inhaled agent, causing inflammatory damage to the pulmonary parenchyma, alveoli and terminal bronchioles.
João Pedro Abreu   +5 more
doaj   +1 more source

The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity

open access: yesFrontiers in Immunology, 2021
The immunomodulatory effects of regulatory T cells (Tregs) and co-signaling receptors have gained much attention, as they help balance immunogenic and immunotolerant responses that may be disrupted in autoimmune and infectious diseases.
Yun-Shiuan Olivia Hsu   +43 more
doaj   +1 more source

Successful desensitization in a patient with adalimumab hypersensitivity

open access: yesClinical Immunology Communications, 2022
Adalimumab is a fully-humanized monoclonal antibody against tumor necrosis factor alpha (TNF-α) that is used to suppress the immune response. Though rare, hypersensitivity reactions to adalimumab can occur.
Samantha Woolery   +3 more
doaj   +1 more source

Urticarial vasculitis: A Complication of SMZ‐TMP therapy

open access: yesClinical Case Reports, 2021
Recognize that delayed hypersensitivity reactions to sulfonamides may present as urticated plaques with hyperpigmentation and purpura for which a diagnosis of urticarial vasculitis should be considered.
Arveen K. Bhasin, Jason C. Sluzevich
doaj   +1 more source

Candidin: comparison of two antigens for cutaneous delayed hypersensitivity testing Candidina: antígeno para reação de hipersensibilidade de tipo tardio. Comparação de dois antígenos

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1996
A candidin, which is a suspension of killed yeast cells, is commonly used for intradermal tests of delayed hypersensitivity, to evaluate the immunological cellular competence of the patient, when the test is applied along with other similar tests.
Celeste Fava-Netto   +4 more
doaj   +1 more source

Delayed Hypersensitivity Reaction after Nipple Tattooing: A Novel Case Report

open access: yesPlastic and Reconstructive Surgery, Global Open, 2019
Summary:. We present a patient who underwent bilateral 3-dimensional (3D) nipple tattooing for nipple areolar reconstruction after implant-based breast reconstruction for breast cancer.
Walter J. Joseph, MD   +2 more
doaj   +1 more source

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis. [PDF]

open access: yesBMC Gastroenterol, 2020
BACKGROUND Eosinophilic esophagitis (EoE) is a chronic inflammatory disease that has been known since the early 1990s. Swallowed topical corticosteroids (STC) belong to the therapeutic cornerstones.
Andrist CM   +5 more
europepmc   +2 more sources

The use of different concentrations of leishmanial antigen in skin testing to evaluate delayed hypersensitivity in american cutaneous leishmaniasis

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 1985
Three concentrations of Leishmania mexicana amazonensis sonicated whole promastigote antigen (30, 9.6 and 3 ug N in 0.1 ml) wereprepared and 0.1 ml of each inoculated intradermally intopatients who live in one endemic leishmaniasis region in Brazil ...
César A. Cuba Cuba   +4 more
doaj   +3 more sources

Cutaneous Reactions after COVID-19 vaccines

open access: yesVaccine Research, 2021
Cutaneous reactions reported post COVID-19 trials range from acute and immediate to delayed reactions. The suspected trigger for hypersensitivity reactions is the inactive ingredients, such as polyethylene glycol in mRNA vaccines and polysorbate 80 in ...
Alicia Wan Yan Poh, Shyh Poh Teo
doaj   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy